Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death.
about
Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stressViral FLICE inhibitory protein of rhesus monkey rhadinovirus inhibits apoptosis by enhancing autophagosome formationNaringenin prevents high glucose-induced mitochondria-mediated apoptosis involving AIF, Endo-G and caspasesProtective role of morin, a flavonoid, against high glucose induced oxidative stress mediated apoptosis in primary rat hepatocytes.Integrated microarray and multiplex cytokine analyses of Kaposi's Sarcoma Associated Herpesvirus viral FLICE Inhibitory Protein K13 affected genes and cytokines in human blood vascular endothelial cells.Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latencyKaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a.KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.Viral latency and its regulation: lessons from the gamma-herpesviruses.Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice.Actin cytoskeleton remodeling by the alternatively spliced isoform of PDLIM4/RIL protein.Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses.A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.Preparation and application of polyclonal antibodiesagainst KSHV v-cyclin.Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV.Utilising proteomic approaches to understand oncogenic human herpesviruses (Review).Deletion of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cellsKaposi's sarcoma-derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell line.O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter.A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation.Oxidative stress induces reactivation of Kaposi's sarcoma-associated herpesvirus and death of primary effusion lymphoma cells.O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.Cell death inhibition by KSHV.
P2860
Q28388436-FEBF6EF1-3517-4A75-945E-210FC6F8320FQ28472699-56AE20BA-761C-4E9E-A43A-88C58267D8ECQ28480552-F0F2E0D3-3896-4228-A2C4-DB6154E83D76Q28570855-B79CD6E2-C255-42A6-B4C2-8BC2558008CCQ31086019-79989B39-50E4-458B-907D-869E2DAA742EQ33491306-556B2B7E-B276-4343-91B8-F07F5F334B69Q33632932-9448147E-4CC0-4111-B4CD-25397AB0EE31Q33753956-B02408D1-D02E-4AC2-9AC7-D09DD0E194CDQ33761091-6365FB26-CC51-464D-978F-70654871EA34Q34039189-C082286C-668A-40FD-A959-413A7565F723Q34616590-D1894042-743B-4ED8-8144-169E178B674AQ35128280-784BFE7F-7122-40F3-ADD1-A228428E50D4Q35720026-2EAE97C8-63B6-4932-AA58-C93874E5C849Q36673788-AF6C9916-3F8D-492E-BD2D-BA10BC4A4CF0Q37199219-2AD4CA7F-E28A-4F7C-BF75-C36BA203BD15Q37810431-3E7609AA-EA98-4628-AE54-DA1D5F453BA6Q38073761-48C8CF71-709D-4A06-BDCE-CBB24B243A47Q38256387-67BB6589-8140-4911-9E0A-74BBA61AF46CQ38748567-0BF0847D-9BC8-461F-911C-5DE6138E8420Q39276602-A54AFF45-BFD8-4E1A-96A9-23A78E0114B5Q39887434-719B44E3-EA04-4ABF-B957-507697583109Q39897858-15F2F4A2-8963-4D7E-BBDA-5F813D438C8BQ42166459-DB819B2B-3B04-45FE-9B7B-A7766996CD20Q42711959-5DFBBD94-4CFB-4B99-8978-9C9653B9ABAEQ43184269-C2B318B9-125F-4285-8747-DE354FD8BC74
P2860
Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Viral inhibitor of apoptosis v ...... superoxide-induced cell death.
@en
Viral inhibitor of apoptosis v ...... superoxide-induced cell death.
@nl
type
label
Viral inhibitor of apoptosis v ...... superoxide-induced cell death.
@en
Viral inhibitor of apoptosis v ...... superoxide-induced cell death.
@nl
prefLabel
Viral inhibitor of apoptosis v ...... superoxide-induced cell death.
@en
Viral inhibitor of apoptosis v ...... superoxide-induced cell death.
@nl
P2093
P2860
P50
P356
P1433
P1476
Viral inhibitor of apoptosis v ...... superoxide-induced cell death
@en
P2093
Frank Neipel
Gaby Marquardt
Kristina Weinländer
Mathias Thurau
Nathalie Gonin-Laurent
Ramona Jochmann
Thomas F Schulz
P2860
P304
P356
10.1128/JVI.00629-08
P407
P577
2008-11-05T00:00:00Z